Press Release
Category Added in a WPeMatico Campaign
-
Business Wire11 hours ago
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease
CADEMPINO, Switzerland–(BUSINESS WIRE)–#ClinicalTrial—Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust…
Read More » -
Oversonic Robotics signs humanoid robots supply agreement with STMicroelectronics
Oversonic to supply custom humanoids to ST’s global network of semiconductor plants Collaborative demo during CES MILAN, Dec. 22,…
Read More » -
Repurchase of Truecaller B shares in week 51, 2025
STOCKHOLM, Dec. 22, 2025 /PRNewswire/ — During week 51, 15-19 December 2025, Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased…
Read More » -
XRP Healthcare® Secures Global Trademark Protection at the Intersection of Healthcare Services and XRP-Powered Payments
Multi-jurisdiction trademark coverage reinforces XRP Healthcare’s position across digital health, pharmacy networks, and XRP-based payment infrastructure DUBAI, UAE, Dec. 22,…
Read More » -
Beko Secures €100 Million Sustainability-Linked Loan from IFC to Drive Global Innovation and Net-Zero Transformation
Beko has secured its first sustainability-linked loan to expand renewable energy capacity, strengthen earthquake resilience, and promote next-generation eco-efficient appliances…
Read More » -
Business Wire12 hours ago
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER,…
Read More » -
Business Wire12 hours ago
KKR Launches European Rail Leasing Platform with Green Mobility Partners
Strategic partnership to scale newly established locomotive and train leasing company into a leading European rail leasing platform FRANKFURT, Germany–(BUSINESS…
Read More » -
Business Wire12 hours ago
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER,…
Read More » -
Business Wire13 hours ago
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma
TOKYO–(BUSINESS WIRE)–$INCY–Incyte Biosciences Japan G.K. today announced approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab)…
Read More » -
Business Wire13 hours ago
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer
TOKYO–(BUSINESS WIRE)–$INCY–Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab)…
Read More »


